-
Courses
Courses
Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
-
University Life
University Life
Each year more than 4,000 choose NUI Galway as their University of choice. Find out what life at NUI Galway is all about here.
-
About NUI Galway
About NUI Galway
Since 1845, NUI Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
-
Colleges & Schools
Colleges & Schools
NUI Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
-
Research & Innovation
Research & Innovation
NUI Galway’s vibrant research community take on some of the most pressing challenges of our times.
-
Business & Industry
Guiding Breakthrough Research at NUI Galway
We explore and facilitate commercial opportunities for the research community at NUI Galway, as well as facilitating industry partnership.
-
Alumni, Friends & Supporters
Alumni, Friends & Supporters
There are over 90,000 NUI Galway graduates Worldwide, connect with us and tap into the online community.
-
Community Engagement
Community Engagement
At NUI Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Prof.Timothy O'Brien
Prof Timothy O'Brien
Dean of the college of Medicine, Nursing and Health Sciences,NU Galway, Director of CCMI and REMEDI.
MB BCh BAO,PhD

Biography
Prof O’Brien is head of the Department of Medicine, director of the Centre for Cell Manufacturing Ireland (CCMI) and the Regenerative Medicine Institute (REMEDI), and dean of the college of Medicine, Nursing and Health Sciences at NUI Galway.
Prof O’Brien is an endocrinologist whose research is focused on the use of advanced therapy medicinal products, such as cells and genes, for the treatment of diabetic complications. Many of his 256 peer-reviewed publications focus on this issue.
Since returning to Ireland following 14 years in the USA, he has established a regenerative medicine research program, led the development of a GMP facility and a Clinical Research Facility in Galway, has been the PI on the first gene and cell therapy trials conducted in Ireland and is a founder of a stem cell company, Orbsen Therapeutics, which has novel and patented stem cell isolation technologies.
Prof O’Brien’s current focus is on translational efforts to evaluate the use of mesenchymal stem cells and repaired endothelial progenitor cells in diabetic complications such as critical limb ischemia.